Your browser doesn't support javascript.
loading
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs.
van der Velden, D L; Hoes, L R; van der Wijngaart, H; van Berge Henegouwen, J M; van Werkhoven, E; Roepman, P; Schilsky, R L; de Leng, W W J; Huitema, A D R; Nuijen, B; Nederlof, P M; van Herpen, C M L; de Groot, D J A; Devriese, L A; Hoeben, A; de Jonge, M J A; Chalabi, M; Smit, E F; de Langen, A J; Mehra, N; Labots, M; Kapiteijn, E; Sleijfer, S; Cuppen, E; Verheul, H M W; Gelderblom, H; Voest, E E.
Affiliation
  • van der Velden DL; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hoes LR; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.
  • van der Wijngaart H; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Berge Henegouwen JM; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.
  • van Werkhoven E; Oncode Institute, Utrecht, The Netherlands.
  • Roepman P; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.
  • Schilsky RL; Oncode Institute, Utrecht, The Netherlands.
  • de Leng WWJ; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Huitema ADR; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.
  • Nuijen B; Oncode Institute, Utrecht, The Netherlands.
  • Nederlof PM; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Herpen CML; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • de Groot DJA; Hartwig Medical Foundation, Amsterdam, The Netherlands.
  • Devriese LA; American Society of Clinical Oncology, Alexandria, VA, USA.
  • Hoeben A; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • de Jonge MJA; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Chalabi M; Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Smit EF; Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • de Langen AJ; Department of Pathology, Molecular Diagnostics Laboratory, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Labots M; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Kapiteijn E; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Sleijfer S; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Cuppen E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Verheul HMW; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Gelderblom H; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Voest EE; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.
Nature ; 574(7776): 127-131, 2019 10.
Article in En | MEDLINE | ID: mdl-31570881
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Discovery / Drug Repositioning / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Nature Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Discovery / Drug Repositioning / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Nature Year: 2019 Document type: Article